We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medtronic has possibly “the deepest pipeline in company history,” setting it up to weather recent marketshare losses and boost growth in the second half of the year, Leerink Swann analyst Danielle Antalffy says. Read More
The deal leverages existing vascular technologies and customer relationships to drive increased market penetration, the Irish devicemaker says. Read More